Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

X T L Biopharmaceuticals Ltd (NASDAQ:XTLB)

1.89
Delayed Data
As of 9:29am ET
 -0.01 / -0.53%
Today’s Change
1.55
Today|||52-Week Range
5.00
-4.55%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Revenue and IncomeNet Revenues0.00937.6K2.4M0.00
 
 
 
Cost of Goods Sold0.00287.9K530.5K0.00
 
 
 
Depreciation And Amortization93.6K135.9K312.9K7.9K
 
 
 
 
 
 
Operating ExpensesGross Income-93.6K513.8K1.5M-7.9K
 
 
 
 
 
General Expenses1.1M3.7M3.8M2.0M
 
 
 
 
 
Other Operating Expenses0.000.000.000.00
 
 
Research And Development69.7K99.0K113.3K274.1K
 
 
 
 
 
Total Operating Expenses1.2M4.1M4.6M2.0M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-1.2M-3.2M-2.2M-2.0M
 
 
 
 
 
Extraordinary Credit0.00794.7K10.0K--
 
 
 
Extraordinary Charge0.00---1.7M--
 
 
Interest Expense On Debt0.000.000.005.9K
 
 
Equity In Earnings0.00568.8K-847.3K0.00
 
 
 
Other Expenses5.0K9.0K1.1M-99.6K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-1.2M-2.3M-2.9M-2.1M
 
 
 
 
 
Minority Interest0.00-351.9K-1.2M0.00
 
 
 
Discontinued Operations0.000.000.00-402.2K
 
 
Net Income-1.2M-1.4M-2.5M-2.5M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS10.1M10.9M11.2M11.6M
 
 
 
 
 
Shares To Calculate EPS Diluted10.1M10.9M11.2M11.6M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.12-$0.12-$0.22-$0.22
 
 
 
 
 
EPS Diluted-$0.12-$0.12-$0.22-$0.22